Profilo
Kristin Bedard served as the Chief Scientific Officer-Immuno oncology at Kineta, Inc. from 2016 to 2020.
She then worked as the Vice President-Immunobiology at Sutro Biopharma, Inc. from 2020 to 2023.
Dr. Bedard completed her undergraduate degree at The Pennsylvania State University in 1998.
She later earned her doctorate degree from the University of California, Irvine in 2005.
Precedenti posizioni note di Kristin Bedard
| Società | Posizione | Fine |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Corporate Officer/Principal | 01/06/2023 |
Kineta, Inc. (Washington)
 Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 01/02/2020 |
Formazione di Kristin Bedard
| The Pennsylvania State University | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Kristin Bedard
